Merck Gets A Headache: Unexpectedly Halts Development Of Migraine Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Meanwhile, the drug maker hopes to file a different drug, talcagepant, to treat acute migraines, but has yet to say when that will happen.